(Press-News.org) The artificial intelligence program "Watson" may have outsmarted human competitors on the television quiz show "Jeopardy!" recently, but it would have to go a long way to best an intelligence analyst, according to Kristan Wheaton, J.D., associate professor of intelligence studies at Mercyhurst College.
On Feb. 14-16, the reigning champions of Jeopardy! – Ken Jennings and Brad Rutter – faced a formidable new competitor – a supercomputer named Watson under development by IBM for four years. Watson defeated his adversaries handily.
Wheaton's graduate students recently completed a study on the future of predictive analytics, which examined the outlook for intelligence analysis in the computerized age, including emerging technologies similar to IBM's "Watson." They delivered their findings Feb. 21 to a representative of one of the nation's leading analytic organizations, which sponsored the study as part of Wheaton's Strategic Intelligence class. For security reasons, the organization declined to be publicly identified.
In their study, Wheaton's students' discovered that the technologies that would completely replace humans with machines in the field of intelligence analysis are not looming on the horizon.
"What you saw on Jeopardy would not play out the same in the world of intelligence analysis today because none of these new technologies – including Watson - deal well with deliberately deceptive data," Wheaton said.
Lindy Smart, one of the student analysts on the project, explained why. "While there are technologies that can extract data from unstructured sources like e-mails and blogs, they are unable to identify the validity of those sources," she said."For example, let's say you want to do a search about mining practices in African countries. The software could extract data from every single type of source identifying mining practices in Africa. However, it would not identify what data came from state-run news sources that would most likely have skewed the data. Humans are still needed to identify and weed out which sources are deceptive and how reliable the data is."
Wheaton added, "The technologies are improving rapidly, though, and there might be machines capable of mimicking human intelligence at some point, but the last job I think they are going to get is that of the intelligence analyst."
### END
Intelligence analysts need not fear 'Watson,' study shows
2011-03-09
ELSE PRESS RELEASES FROM THIS DATE:
UCLA performs first hand transplant in the western United States
2011-03-09
Surgeons at Ronald Reagan UCLA Medical Center performed the first hand transplant in the western United States in an operation that began one minute before midnight on Friday, March 4, and was completed 14-and-a-half hours later, on Saturday, March 5.
The transplant was performed on a 26-year-old mother from Northern California who lost her right hand in a traffic accident nearly five years ago. UCLA is only the fourth center in the nation to offer this procedure, and the first west of the Rockies. This was the 13th hand transplant surgery performed in the United States. ...
Text messaging helps smokers break the habit
2011-03-09
EUGENE, Ore. -- A pair of related studies on smoking cessation by researchers at the University of Oregon and other institutions have isolated the brain regions most active in controlling urges to smoke and demonstrated the effectiveness of text-messaging to measure and intervene in those urges.
Both projects used the same group of test subjects -- 27 heavy smokers recruited from the American Lung Association's Freedom From Smoking program in Los Angeles.
Elliot Berkman, professor of psychology at the UO, and colleagues Emily Falk at the University of Michigan and Matthew ...
3-D tracking of single molecules inside cells
2011-03-09
WASHINGTON, D.C. (March 8, 2011) -- Researchers at the University of Texas Southwestern Medical Center and the University of Texas at Dallas are reporting today at the 55th Annual Biophysical Society Annual Meeting in Baltimore, MD how they are using a novel 3D cell imaging method for studying the complex spatial-temporal dynamics of protein transport, providing a solution to this fundamental problem in cell biology.
According to the authors of the study, imaging such highly dynamic processes in the cell and in 3D poses major technical challenges in a complex cell monolayer ...
Secrets of plague revealed
2011-03-09
WASHINGTON, D.C. (March 8, 2011) -- In work that is pushing the "diffraction barrier" associated with microscopic imaging of living cells, researchers at Sandia National Laboratories in Albuquerque, NM demonstrated the power of a new super-resolution microscopy technique called Stochastic Optical Reconstruction Microscopy (STORM), which can simultaneously image multiple molecules in living immune cells.
As described today at the 55th Annual Biophysical Society Annual Meeting in Baltimore, MD, Jesse Aaron and Jerilyn Timlin used this new technique to reveal the changes ...
Team uncovers dengue fever virus' molecular secrets
2011-03-09
WASHINGTON, D.C. (March 8 2011) -- Researchers at the Instituto de Medicina Molecular in Lisbon, Portugal and the Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil, are making major strides toward understanding the life cycle of flaviviruses, which include some of the most virulent human pathogens: yellow fever virus, Dengue virus, and the West Nile Virus, among others.
Today, at the 55th Annual Meeting of the Biophysical Society in Baltimore, MD, members of the team will report on studies using dengue virus as a model to elucidate the molecular details ...
Making viruses pass for 'safe'
2011-03-09
WASHINGTON, D.C. (March 8 2011) -- Viruses can penetrate every part of the body, making them potentially good tools for gene therapy or drug delivery. But with our immune system primed to seek and destroy these foreign invaders, delivering therapies with viruses is currently inefficient and can pose a significant danger to patients.
Now scientists at the University of Pennsylvania have engineered a virus with potential to solve this problem. They describe the new virus today at the 55th Annual Biophysical Society Meeting in Baltimore, MD.
"We would like to find a way ...
New instrument for analyzing viruses
2011-03-09
WASHINGTON, D.C. (March 8, 2011) -- Scientists in Israel and California have developed an instrument for rapidly analyzing molecular interactions that take place viruses and the cells they infect. By helping to identify interactions between proteins made by viruses like HIV and hepatitis and proteins made by the human cells these viruses infect, the device may help scientists develop new ways of disrupting these interactions and find new drugs for treating those infections.
According to Doron Gerber, a professor at Bar Ilan University in Ramat Gan, the PING system (Protein ...
Improving risk/benefit estimates in new drug trials
2011-03-09
It's all too familiar: researchers announce the discovery of a new drug that eradicates disease in animals. Then, a few years later, the drug bombs in human trials. In the latest issue of the journal PLoS Medicine, ethics experts Jonathan Kimmelman, associate professor at McGill's Biomedical Ethics Unit and Department of Social Studies of Medicine, and Alex John London, associate professor of philosophy at Carnegie Mellon University, argue that this pattern of boom and bust may be related to the way researchers predict outcomes of their work in early stages of drug development.
"We ...
No link between economic growth and child undernutrition rates in India
2011-03-09
Economic growth in India has no automatic connection to reducing undernutrition in Indian children and so further reductions in the prevalence of childhood undernutrition are likely to depend on direct investments in health and health-related programs. These are the conclusions of a large study by researchers at the Schools of Public Health at University of Michigan and Harvard University, that is published in this week's PLoS Medicine.
Malavika Subramanyam, S V Subramanian and colleagues collected data from the National Family Health Surveys conducted in India in 1992-93 ...
IRBs could use pre-clinical data better
2011-03-09
In this week's PLoS Medicine, Jonathan Kimmelman from McGill University in Montreal, Canada and Alex London from Carnegie Mellon University in Pittsburgh, USA argue that ethical reviewers and decision-makers pay insufficient attention to threats to validity in pre-clinical studies and consult too narrow a set of evidence. They propose a better way for ethical and scientific decision makers to assess early phase studies: first, to attend to reporting and methodological quality in preclinical experiments that support claims of internal, construct, and external validity; and ...